CompletedNot Applicable

Philips FAST Evaluation

United States27 participantsStarted 2025-03-11

Plain-language summary

Evaluation of Philips FAST technology with Nellcor sensors

Age range18 Years – 50 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✕. Subject is considered as being morbidly obese (defined as BMI \>39.5)
✕. Compromised circulation, injury, or physical malformation of fingers, hands, ears or forehead/skull or other sensor sites which would limit the ability to test sites needed for the study (Note: Certain malformations may still allow subjects to participate if the condition is noted and would not affect the sites utilized)
✕. Participants of childbearing potential who are pregnant, who are trying to get pregnant, or who have a urine test positive for pregnancy on the day of the study
✕. Subjects with COHb levels \>3% as assessed by CO-Oximetry during the procedure
✕. tHb \< 10 g/dl as assessed by CO-Oximetry during the procedure
✕. MetHb ≥ 2% as assessed by CO-Oximetry during the procedure
✕. Subjects with known respiratory conditions such as:
✕. uncontrolled / severe asthma

Evaluation of Saturation Accuracy

Timeframe: 2 - 3 hours

NCT IDNCT06860230

SponsorMedtronic - MITG

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2025-04-11